Zobrazeno 1 - 10
of 302
pro vyhledávání: '"Ethan Dmitrovsky"'
Autor:
Cheng-Hsin Wei, Lu Huang, Blair Kreh, Xiuxia Liu, Liliya Tyutyunyk-Massey, Masanori Kawakami, Zibo Chen, Mi Shi, Serguei Kozlov, King C. Chan, Thorkell Andresson, Mary Carrington, Vidyasagar Vuligonda, Martin E. Sanders, Amir Horowitz, Patrick Hwu, Weiyi Peng, Ethan Dmitrovsky, Xi Liu
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract All-trans-retinoic acid (ATRA), the retinoic acid receptors (RARs) agonist, regulates cell growth, differentiation, immunity, and survival. We report that ATRA-treatment repressed cancer growth in syngeneic immunocompetent, but not immunodef
Externí odkaz:
https://doaj.org/article/3a6d32daebaf4a6c91b60abe62aa93bd
Autor:
Zibo Chen, Lin Zheng, Yulong Chen, Xiuxia Liu, Masanori Kawakami, Lisa Maria Mustachio, Jason Roszik, Katherine V. Ferry-Galow, Ralph E. Parchment, Xin Liu, Thorkell Andresson, Gerard Duncan, Jonathan M. Kurie, Jaime Rodriguez-Canales, Xi Liu, Ethan Dmitrovsky
Publikováno v:
Cancer Biology & Therapy, Vol 23, Iss 1, Pp 265-280 (2022)
Cancer metastasis is a major cause of cancer-related mortality. Strategies to reduce metastases are needed especially in lung cancer, the most common cause of cancer mortality. We previously reported increased ubiquitin-specific peptidase 18 (USP18)
Externí odkaz:
https://doaj.org/article/89c6b8309f354ba2877fae72139376be
Publikováno v:
The Scientific World Journal, Vol 9, Pp 626-628 (2009)
Externí odkaz:
https://doaj.org/article/c1acb5f77c854d3d8c5cfc481ad48756
Autor:
Jason Roszik, J. Jack Lee, Yi-Hung Wu, Xi Liu, Masanori Kawakami, Jonathan M. Kurie, Anas Belouali, Simina M. Boca, Samir Gupta, Robert A. Beckman, Subha Madhavan, Ethan Dmitrovsky
Publikováno v:
Cancer Research Communications. 2:590-601
Inflammation is a cancer hallmark. NSAIDs improve overall survival (OS) in certain cancers. Real-world studies explored here whether NSAIDs improve non–small cell lung cancer (NSCLC) OS. Analyses independently interrogated clinical databases from T
Autor:
Ethan Dmitrovsky, Subha Madhavan, Robert A. Beckman, Samir Gupta, Simina M. Boca, Anas Belouali, Jonathan M. Kurie, Masanori Kawakami, Xi Liu, Yi-Hung Wu, J. Jack Lee, Jason Roszik
Supplementary Table 6: The MD Anderson cohort 5-year survival rate and difference of 5-year restricted mean survival time in months between NSAID users and non-users by gender, race, and smoking status corresponding to Figure 2. Comparisons are made
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::489e36f981abf8244fc8cb7a0cc4a67e
https://doi.org/10.1158/2767-9764.22545657
https://doi.org/10.1158/2767-9764.22545657
Autor:
Ethan Dmitrovsky, Subha Madhavan, Robert A. Beckman, Samir Gupta, Simina M. Boca, Anas Belouali, Jonathan M. Kurie, Masanori Kawakami, Xi Liu, Yi-Hung Wu, J. Jack Lee, Jason Roszik
Supplemental Figure 2. The Kaplan-Meier analysis of overall survival and NSAID use in lung cancer cases within the MedStar-Georgetown University database (Georgetown cohort).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a8b31f54f3727dbff9179670f7d3af
https://doi.org/10.1158/2767-9764.22545684.v1
https://doi.org/10.1158/2767-9764.22545684.v1
Autor:
Ethan Dmitrovsky, Subha Madhavan, Robert A. Beckman, Samir Gupta, Simina M. Boca, Anas Belouali, Jonathan M. Kurie, Masanori Kawakami, Xi Liu, Yi-Hung Wu, J. Jack Lee, Jason Roszik
Inflammation is a cancer hallmark. NSAIDs improve overall survival (OS) in certain cancers. Real-world studies explored here whether NSAIDs improve non–small cell lung cancer (NSCLC) OS. Analyses independently interrogated clinical databases from T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::489eb539d942d0314d48d9d9b9e2f267
https://doi.org/10.1158/2767-9764.c.6550998.v1
https://doi.org/10.1158/2767-9764.c.6550998.v1
Autor:
Ethan Dmitrovsky, Sarah J. Freemantle, Xi Liu, Shanhu Hu, Fadzai Chinyengetere, John F. Hancock, Kwang-jin Cho, Masanori Kawakami, Jason Roszik, Samir M. Hanash, Hiroyuki Katayama, Ignacio Wistuba, Pamela Andrea Villalobos, Barbara Mino, Jaime Rodriguez-Canales, Vincent Memoli, Laura J. Tafe, Yun Lu, Lisa Maria Mustachio
KRAS is frequently mutated in lung cancers and is associated with aggressive biology and chemotherapy resistance. Therefore, innovative approaches are needed to treat these lung cancers. Prior work implicated the IFN-stimulated gene 15 (ISG15) deubiq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd5c9584958b0a004b044ec7e99060a1
https://doi.org/10.1158/1541-7786.c.6539967.v1
https://doi.org/10.1158/1541-7786.c.6539967.v1
Autor:
Ethan Dmitrovsky, Sarah Freemantle, Duane A. Compton, David Sekula, Masanori Kawakami, Lisa Maria Mustachio, Kristina Godek, Bernardo Orr, Yun Lu, Shanhu Hu
Knock-down of Usp33 in murine lung cancer cells does not affect CP110 protein expression. Effects of Usp33 knock-down at 24,48, 72 and 96 hours on CP110 expression in ED-1 cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df3c9b4dab96bc8e6fe93915d34e495
https://doi.org/10.1158/1535-7163.22505949
https://doi.org/10.1158/1535-7163.22505949
Autor:
Ethan Dmitrovsky, Sarah J. Freemantle, Duane A. Compton, Faye M. Johnson, Masanori Kawakami, Xi Liu, David Sekula, Lisa Maria Mustachio, Kristina Godek, Bernardo Orr, Shanhu Hu, Alexey V. Danilov
Movie video files of a) H1299 and b) HOP62 cells were treated with 25 or 50 nM dinaciclib and continuously imaged as described in the Methods.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9069a8a0528305d25c2d498b03683e42
https://doi.org/10.1158/1535-7163.22506325.v1
https://doi.org/10.1158/1535-7163.22506325.v1